ValiRx
Executives
View the org chart displaying its 11 main executives
Most searched biographies at ValiRx
- Suzanne Dilly, Director and Chief Executive Officer
- Kevin Cox, Non-Executive Chairman of the Board
- Martin Lampshire, Non-Executive Director
Popular executive movements at ValiRx
- Adrian de Courcey has joined the company as Non-Executive Director (posted on April 22 2024).
- Luke Cairns has joined the company as Independent Non-Executive Director (posted on March 4 2024).
- Martin Gouldstone has joined the company as Non-Executive Director (posted on March 1 2024).
Click here to view some more movements at ValiRx
Create your alert
to follow the executive moves at ValiRx.
Biotechnology
ValiRx has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by ValiRx
- ValiRx news round-up: March 2024 | ValiRx PLC
- ValiRx plc - Signed Evaluation Agreement with Imperial College London | ValiRx PLC
- News | ValiRx PLC
- ValiRx news round-up: January & February 2024 | ValiRx PLC
- ValiRx strikes deal with Ambrose Healthcare | ValiRx PLC
- ValiRx PLC - Agreement signed with Dundee University | ValiRx PLC
- ValiRx 2023: A year in review | ValiRx PLC
- ValiRx Q&A Webinar December 2023 | ValiRx PLC
- ValiRx strikes deal with Ambrose Healthcare to license late-stage cancer treatment | ValiRx PLC
- ValiRx - Agreement to License VAL401 | ValiRx PLC
- View more press releases Close
Social media about ValiRx
- ValiRx on Wikipedia, Google News & Yahoo Finance
- ValiRx on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Suzanne Dilly 
